Galderma

At Galderma, our products and career opportunities are designed to honor and embrace individuality. Experience our dynamic culture and dedication to pushing the boundaries of dermatology. Come be part of our team and create a meaningful impact in our growth journey! Your future starts here: https://lnkd.in/eEYDGzzK #JoinUs #Careers

Technologies powered by AI and AR are transforming what’s possible in dermatology, especially in injectable aesthetics. For example, thanks to ‘dermatology technology’ capabilities such as advanced facial assessment and treatment visualization, patients can now obtain ‘before/after’ images before having a procedure.  At Galderma, we strive to empower people with the tools to feel confident in their skin. But how exactly can technology respond to patient needs and emerging trends? Read our Q&A with Galderma’s Head of Global Product Strategy, Gerry Muhle to learn the ways in which innovative dermatology technology is bringing patients closer to achieving their skin goals: #AdvancingDermatology #AI #Aesthetics

We are proud to announce that results from our phase III trial on the treatment of moderate-to-severe frown lines have been published in the The Aesthetic Society's Aesthetic Surgery Journal. We want to thank the investigators and lead author, @Dr Sachin Shridharani for their hard work and encourage you to read more on the results here: https://bit.ly/3VZlWi3   #AdvancingDermatology

The Global Sensitive Skincare Faculty (GSSF) brings together the collective expertise, knowledge, experience, and dedication of esteemed experts, researchers, and healthcare professionals from around the world to advance the science of sensitive skin. Dr. Krzysztof Piotrowski, is the co-chair of the Global Sensitive Skincare Faculty by Galderma, overseeing its evolution across three key pillars: research & science, engagement, and education.  Last year, we engaged 10,500 subjects in an epidemiological survey across 7 countries and 5 continents, enriching the understanding of sensitive skin and its impact worldwide. And there is much more to come. #GSSF #AdvancingDermatology #SensitiveSkin

The Global Sensitive Skincare Faculty (GSSF) works together to expand our understanding of sensitive skin by filling evidence gaps and advancing emerging areas of sensitive skin science through research led by Nadège LACHMANN, head of our research & science pillar; inspiring the development of new solutions to improve management and care; and shaping the future of best practice by enhancing the knowledge of healthcare professionals around the world. Last year, we conducted an extensive profiling of sensitive skin on a global scale, contributing valuable insights into this dermatological condition. #GSSF #AdvancingDermatology #SensitiveSkin

Galderma's new Global Capability Center was officially inaugurated yesterday in Barcelona. During the ceremony our CEO Flemming Ornskov, MD, MPH emphasized how Barcelona’s rich talent pool, top-notch educational institutions, and fantastic lifestyle make it the perfect location to support our continuous growth. Our new, vibrant offices on the city center span 1,500 square meters and are buzzing with energy from our diverse team of over 110 people, representing talent from 22 different countries; support our global teams in R&D, commercial, finance, HR, IT, legal, and supply chain. Alongside our employees, we were delighted to host special guests including Othmar Hardegger, Consulado General de Suiza en Barcelona, Joan Romero i Circuns, Executive Director of ACCIÓ from the Generalitat de Catalunya, and other representatives from Barcelona City Council, Esade, as well as members of the media. #AdvancingDermatology #Careers #JoinUs

Galderma announced today that the Swedish Medical Products Agency (Läkemedelsverket) issued key manufacturing license updates for new biologics capabilities at its center of excellence.   This will enable Galderma to pursue its ambitious growth and innovation roadmap, and increase its autonomy in bringing new blockbuster platforms to market in dermatology.   Read more: https://lnkd.in/eC-XgyCU #AdvancingDermatology 

Help protect against permanent acne scarring by speaking to a doctor.¹Learn more about acne scarring and risk factors here: https://lnkd.in/dBB5Vy4B #AdvancingDermatology #AcneAware References: 1. Dreno B and Stein-Gold L. Dermatol Ther (Heidelb). 2021;11:1075–1078.

At Galderma, we’re united in our purpose to advance dermatology for every skin story. While science-based innovation drives us, it’s people who inspire our work. This dedication is underscored by our continued support of Children's Skin Disease Foundation/Camp Wonder. This weekend, children across the U.S. living with chronic and often life-threatening skin conditions are heading to the annual sleepaway camp to partake in seven days of fun with a community of peers. At Galderma, we’re dedicated to accompanying our network through each step of their skin journey. That’s why we’re proud to support initiatives like Camp Wonder, which empower each and every skin story. #AdvancingDermatology #CampWonder

On average, skin sensitivity affects 70% of people around the world. The Global Sensitive Skincare Faculty (GSSF) is dedicated to enhancing our understanding of sensitive skin and what makes it a standalone condition that needs specific care. Follow us to learn more about how we're advancing the science of sensitive skin globally. Prof. Adam Friedman is Chair of Dermatology at The George Washington University and co-chair of the Global Sensitive Skincare Faculty by Galderma. #SensitiveSkin #GSSF #AdvancingDermatology  ---- Citations:  1&3 Misery L, et al. Acta Derm Venereol 2017  2 Misery L. Peaux sensibles, peaux réactives [Sensitive skin, reactive skin]. Ann Dermatol Venereol. 2019 Sep;146(8-9):585-591. French. doi: 10.1016/j.annder.2019.05.007. Epub 2019 Jul 15. PMID: 31320184. 4 Misery L, et al. Sensitive Skin Syndrome: A Low-Noise Small-Fiber Neuropathy Related to Environmental Factors? Front Pain Res (Lausanne). 2022 Mar 25;3:853491. doi: 10.3389/fpain.2022.853491. PMID: 35399156; PMCID: PMC8990967. 5 Pellacani G, et al. Poster 0759. EADV 2021.